News

WALTHAM, MA — January 9, 2023 — CorEvitas, LLC, the leading sponsor of syndicated clinical registries in autoimmune and inflammatory diseases, has launched and is recruiting patients in a first-of-its-kind registry to evaluate the safety and effectiveness of newly approved therapies for patients...Learn More

News

Investment augments CorEvitas’ pharmacovigilance services to fulfill global regulatory requirements for the safety of medications and vaccines during pregnancy

Waltham, MA and Los Angeles, CA, November 22, 2022 – CorEvitas, LLC (“CorEvitas”), an industry leader in syndicated registries,...Learn More

News

Waltham, MA and London, UK, July 6, 2022 — CorEvitas, LLC is excited to announce expanded services to include specialty EMR data through its Specialty EMR Data Business Unit. Health iQ Limited, a subsidiary of CorEvitas, has provided innovative real-world evidence solutions in...Learn More

News

Panelists explore how connecting claims and clinical registry data lead to a better understanding of the patient journey

Waltham, MA and Bowie, MD, May 11, 2022—CorEvitas, LLC, the built-for-purpose provider of real-world evidence, and Inovalon, a leading...Learn More